Paper33744718
STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications.
Krishnamurthy N and 3 others. Eur J Cancer, 2021. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications. Papers, record 33744718. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33744718
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Circulating Tumor DNA | Major topic |
| Immunotherapy | Major topic |
| Mutation | Major topic |
| Neoplasms | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| AMP-Activated Protein Kinase Kinases | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Survival Rate | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA023100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH |
Source NIH RePORTER
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31003990 | Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/31003990 | PubMed |
| 2 | 9428765 | A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. | Nature | 1998 | https://conductscience.org/library/papers/9428765 | PubMed |
| 3 | 31757465 | Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients. | Gynecol Oncol | 2020 | https://conductscience.org/library/papers/31757465 | PubMed |
| 4 | 12114407 | The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. | Clin Cancer Res | 2002 | https://conductscience.org/library/papers/12114407 | PubMed |
| 5 | 32312757 | STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort. | ESMO Open | 2020 | https://conductscience.org/library/papers/32312757 | PubMed |
| 6 | 26069186 | Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. | Cancer Discov | 2015 | https://conductscience.org/library/papers/26069186 | PubMed |
| 7 | 31405947 | Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/31405947 | PubMed |
| 8 | 30885352 | Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11. | Lung Cancer | 2019 | https://conductscience.org/library/papers/30885352 | PubMed |
| 9 | 27220963 | Focal Adhesion Kinase Regulates the DNA Damage Response and Its Inhibition Radiosensitizes Mutant KRAS Lung Cancer. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/27220963 | PubMed |
| 10 | 28754670 | Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma. | Cancer Res | 2017 | https://conductscience.org/library/papers/28754670 | PubMed |
| 11 | 24142049 | Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/24142049 | PubMed |
| 12 | 19541609 | mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19541609 | PubMed |
| 13 | 10362809 | Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10362809 | PubMed |
| 14 | 26477306 | Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. | Oncogene | 2016 | https://conductscience.org/library/papers/26477306 | PubMed |
| 15 | 26833127 | STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment. | Cancer Res | 2016 | https://conductscience.org/library/papers/26833127 | PubMed |
| 16 | 28550065 | Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant. | Cold Spring Harb Mol Case Stud | 2017 | https://conductscience.org/library/papers/28550065 | PubMed |
| 17 | 23637231 | LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23637231 | PubMed |
| 18 | 24093679 | AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. | Cell Metab | 2013 | https://conductscience.org/library/papers/24093679 | PubMed |
| 19 | 23714478 | Molecular profiling and the reclassification of cancer: divide and conquer. | Am Soc Clin Oncol Educ Book | 2013 | https://conductscience.org/library/papers/23714478 | PubMed |
| 20 | 19340305 | Somatic LKB1 mutations promote cervical cancer progression. | PLoS One | 2009 | https://conductscience.org/library/papers/19340305 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738366 | STK11/LKB1 Loss in Cancer: From Developmental Constraint to Stress-Adapted Malignancy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738366 | PubMed |
| 42668477 | PTC124 promotes mutation site-dependent readthrough of STK11 nonsense mutations and restores tumor suppressor function. | BBA Adv | 2026 | https://conductscience.org/library/papers/42668477 | PubMed |
| 42570967 | Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42570967 | PubMed |
| 42545603 | STK11 c.1062 C > G germline variant in medullary thyroid carcinoma: implications for familial predisposition and genetic counseling. | Endocrine | 2026 | https://conductscience.org/library/papers/42545603 | PubMed |
| 42377736 | Clinical Outcomes Associated with Single STK11 Mutations and Those Co-occurring with KEAP1 and KRAS Mutations in Metastatic Non-Small Cell Lung Cancer. | Adv Ther | 2026 | https://conductscience.org/library/papers/42377736 | PubMed |
| 41636935 | Lineage plasticity: a new dilemma in lung cancer treatment. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41636935 | PubMed |
| 41586744 | Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41586744 | PubMed |
| 41574700 | Deciphering the CAF‑LCN2 axis: Key to overcoming anti‑PD‑L1 immunotherapy resistance in lung cancer. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41574700 | PubMed |
| 41520156 | Actionable genomic landscape of biliary tract cancer in the Indian population. | Oncologist | 2026 | https://conductscience.org/library/papers/41520156 | PubMed |
| 41230344 | Case Report: From teratoma to adenocarcinoma: molecular insights into somatic-type malignancy in testicular germ cell tumors - two case reports and review of the literature. | Pathol Oncol Res | 2025 | https://conductscience.org/library/papers/41230344 | PubMed |
| 41143909 | Clinicopathological characterization of female genital tract cancers with STK11 alterations: redefining the spectrum beyond STK11 adnexal tumors. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41143909 | PubMed |
| 41051525 | Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/41051525 | PubMed |
| 40860288 | Genetic Investigation and Transcriptome Profiling in a Nuclear Family With Peutz-Jeghers Syndrome. | Hum Mutat | 2025 | https://conductscience.org/library/papers/40860288 | PubMed |
| 40647497 | Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647497 | PubMed |
| 40611261 | Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle? | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40611261 | PubMed |
| 40230896 | Breast cancer histopathology, classification and clinical management: Current perspectives. | Bioinformation | 2024 | https://conductscience.org/library/papers/40230896 | PubMed |
| 40183852 | Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/40183852 | PubMed |
| 40102938 | Serine/threonine kinase 11 (STK11) associated adnexal tumors: from biology to therapeutic impact. | Hum Genomics | 2025 | https://conductscience.org/library/papers/40102938 | PubMed |
| 40083325 | Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy. | Genes Dis | 2025 | https://conductscience.org/library/papers/40083325 | PubMed |
| 39934475 | Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers. | Hum Genet | 2025 | https://conductscience.org/library/papers/39934475 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33744718
GET https://conductscience.org/api/papers/v1/33744718/references?page=2